SecBot SecBot

AIMDW

Ainos, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. TX· CIK 0001014763 Biotech & Drug Discovery
Warrants of Ainos, Inc. · AIMD stock page →
—
Market cap
$494.7K
Nano cap
1 year
−78.0%
from $3.62 · Oct 28
30 days
−40.3%
from $1.33
52-week range
$0.7830–3.64
−78% from high · low Oct 26
Avg volume 20D
40.4K
Sep 30 spike 136.2K
Short interest
189
≈0.0% of shares · −93.7%
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersCOVERING

    Short interest −93.7% to 189 shares. 1.0 days to cover, ≈0.0% of shares.

  • TrendDOWNTREND

    38% below its 50-day average. New closing low $0.7830 on Oct 26.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGTRIM576$67.00
UBS Group AGTRIM1,376$169.00
UBS Group AGTRIM2,312$428.00
UBS Group AGNEAR_EXIT6,996$1.0K
UBS Group AGDOUBLED32,538$3.6K

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
189
shares short
-93.7%
vs prior settlement
1.0
days to cover
≈0.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 13, 2026 SEC
Ainos reported Q1 2026 revenue of $161, a 99.8% decline YoY from $106,207, with a net loss of $2.46M (improved from…
8-K — Impact 7/10
Mar 31, 2026 Inst.
UBS Group AG — TRIM
576 shares ($67.00)
Dec 31, 2025 Inst.
UBS Group AG — TRIM
1,376 shares ($169.00)

SecBot reports

1 filing · 0 bullish · 1 bearish
All AIMDW filing & press-release reports (1)